Member Login
  1. Stocks
    2. /
  2. BELLUS Health Inc. (TSX: BLU)
    3. /

TSX:BLU (BELLUS Health Inc.)

About BLU

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • BELLUS Health Inc. (TSX: BLU) Latest News

    Investing

    3 Growth Stocks up Over 50% in 2022

    | Ambrose O'Callaghan

    Canadians on the hunt for growth stocks in should look to equities like Sierra-Wireless Inc. (TSX:SW)(NASDAQ:SWIR) and others today.

    Read more »

    A person builds a rock tower on a beach.
    Dividend Stocks

    3 Stocks To Keep Your Retirement Savings Growing Faster Than Inflation

    | Adam Othman

    The right mix of growth stocks can help you outpace inflation, on the road to retirement.

    Read more »

    Biotech machine with the text “Top Biotech Stocks in Canada” and The Motley Fool jester cap logo
    Page

    Top Biotech Stocks in Canada of 2024

    | Steven Porrello

    Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new…

    Read more »

    A worker uses a laptop inside a restaurant.
    Investing

    3 Simple TSX Stocks to Buy With $25 Right Now

    | Adam Othman

    Investing, even if you have minimal capital to invest with, is a good habit. It prevents your savings (in cash)…

    Read more »

    Investing

    TFSA Investors: 3 Stocks That Haven’t Lost Money in 2022

    | Adam Othman

    Many investors have lost money since the beginning of the year due to a market-wide slump. However, there are still…

    Read more »

    Investing

    Parabolic Returns in 2022 Are Possible From 3 Growth Stocks

    | Christopher Liew, CFA

    Three TSX growth stocks could still deliver parabolic returns in 2022, despite inflationary pressures.

    Read more »

    Biotech stocks
    Coronavirus

    Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

    | Amy Legate-Wolfe

    The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

    Read more »

    TSX Today
    Metals and Mining Stocks

    TSX Today: What to Watch for in Stocks on Tuesday, December 14

    | Jitendra Parashar

    TSX stocks might open on a mixed note Tuesday following a choppy movement in the commodities market early this morning.

    Read more »

    Coronavirus

    Why BELLUS Health Exploded 60% on Monday

    | Amy Legate-Wolfe

    BELLUS Health (TSX:BLU)(NASDAQ:BLU) shares soared after positive results from its recent trial for the treatment of chronic cough.

    Read more »

    Investing

    The 50% Healthcare Index Dip and a Silver Lining

    | Adam Othman

    The individual elements/companies within the healthcare sectors move in less harmony than most other sectors, but a huge sector-wide discount…

    Read more »

    Stocks for Beginners

    2 Canadian Healthcare Stocks That Are All-Stars in the Making

    | Daniel Da Costa

    These two top Canadian healthcare stocks are both analyst favourites and offer some of the best growth potential of any…

    Read more »

    Stocks for Beginners

    4 Canadian Stocks That Could Soar 68% or More According to Bay Street

    | Daniel Da Costa

    If you're looking for Canadian growth stocks to buy, these four Canadian companies are some of the best opportunities on…

    Read more »